Journals / Journal of Mood Disorders / 2015 / Cilt: 5 - Sayı: 2

A case of tourette s disorder with obsessive compulsive symptoms which was treated sucessfully with apiprazole

Aripiprazol Tedavisine Yanıt Veren Obsesif Kompulsif Bozukluğu Olan Bir Tourette Sendromu Vakası

Pages
83–87
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We aimed to present a case of Tourettedisorder with refractory obsessive symptoms and tics whowas treated succesfully with aripiprazol which differs fromother typical and atypical antipsychotics due to its actionof mechanism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Tourette s disorder (TD) is a disease mostly characterizedwith repeated motor and vocal tics.
📊
Key Findings & Data:While highly potentdrugs such as trifluoperazin, pimozide, haloperidol etc.have been used for many years, adrenergic agonists suchas clonidine and guanfacine have been preferred in thetreatment of severe cases.
💡
Conclusion & Impact:We aimed to present a case of Tourettedisorder with refractory obsessive symptoms and tics whowas treated succesfully with aripiprazol which differs fromother typical and atypical antipsychotics due to its actionof mechanism.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Tourette s disorder (TD) is a disease mostly characterizedwith repeated motor and vocal tics. While highly potentdrugs such as trifluoperazin, pimozide, haloperidol etc.have been used for many years, adrenergic agonists suchas clonidine and guanfacine have been preferred in thetreatment of severe cases. Hence their high potency wasproved in controlled trials and case reports and favourableside effect profiles of these agents, atypical antipsyh- chotics such as risperidon, ziprasidon and olanzapin areused commonly. We aimed to present a case of Tourettedisorder with refractory obsessive symptoms and tics whowas treated succesfully with aripiprazol which differs fromother typical and atypical antipsychotics due to its actionof mechanism.

Özet

Tourette bozukluğu (TB) çoğunlukla yineleyen motor vevokal tiklerle karakterize bir hastalıktır. Uzun yıllar tedavisinde haloperidol, trifluoperazin ve pimozid gibi etki gücüyüksek olan klasik antipsikotik ilaçlar kullanılmış, şiddetliolgularda adrenerjik agonist olan klonidin ve guanfasintercih edilmiştir. Son dönemde ise yan etki profilinin dahaiyi olması, vaka sunumları ve kontrollü çalışmalarda etkinliğinin gösterilmesiyle risperidon, ziprasidon, olanzapingibi atipik antipsikotikler yaygın olarak kullanılmaktadır.Biz direnç gösteren obsesif semptomları ve tikleri olanbir vakada mekanizması açısından hem tipiklerden hemde atipiklerden ayrılan aripiprazol kullanımına kısa süredecevap veren bir Tourette bozukluğu olgusunu bildirmeyiamaçladık.

🔖

Cite This Article

UZ, E. G., ÖZTÜRK, D. C. (2022). A case of tourette s disorder with obsessive compulsive symptoms which was treated sucessfully with apiprazole. Journal of Mood Disorders, Cilt: 5 - Sayı: 2, 83–87. https://ajindex.com/articles/564582

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Toros F, Tot Ş, Avcı A. Çocuk ve ergenlerde Tourette bozukluğu: sosyodemografik, klinik özellikler ve eş tanılar. Türk Psikiyatri Dergisi. 2004;13:187-96
  2. Scahill L, Sukhodolsky DG, Williams SK, Leckman JF. Public health significance of tic disorders in children and adolescents. Adv Neurol. 2005;96:240-8
  3. Khalifa N, von Knorring AL. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol. 2003;45:315–19
  4. Centers for Disease Control and Prevention (CDC) Prevelance of diagnosed Tourette syndrome in persons aged 6-17 years - United States, 2007.MMWR Morb Mortal Wkly Rep. 2009;58:581-5
  5. Robertson MM. The Gilles de la Tourette Syndrome: the current status. Arch Dis Child Educ Pract Ed. 2012;97:166-75
  6. Kaplan&Sadock’s Concise Textbook of Clinical Psychiatry, Benjamin James Sadock, Virginia Alcott Sadock; 557-9
  7. Carter AS, Pauls DL, Leckman JF, Cohen DJ. A prospective longitudinal study of Gilles de la Tourette’s syndrome. J Am Acad Child Adolesc Psychiatry. 1994;33:377-85
  8. Jankovic J. Tourette’s syndrome. N Engl J Med. 2001;345:1184-92
  9. Bloch MH, Leckman JF. Tic disorders. In Lewis’s Child and Adolescent Psychiatry: A Comprensive Textbook, 4th ed. (Eds A Martin, FR Volkmar):569-83. Philadelphia, Lippincott Williams Wilkins, 2007
  10. Braun AR, Stoetter B, Randolph C, Hsiao JK, Vladar K, Gernert J et al. The functional neuroanatomy of Tourette’s syndrome: an FDG- PET study. I: regional changes in cerebral glucose metabolism differentiating patients and controls. Neuropsychopharmacology. 1993;9:277-91
  11. Braun AR, Randolph C, Stoetter B, Mohr E, Cox C, Vladar K et al. The functional neuroanatomy of Tourette’s syndrome: an FDG- PET study. II: relationships between regional cerebral metabolism and associated behavioral and cognitive features of the illness. Neuropsychopharmacology. 1995;13:151-68
  12. Roessner V, Schoenefeld K, Buse J, Bender S, E Stefan, Münchau A. Pharmacological treatment of tic disorders and Tourette Syndrome. Neuropharmacology. 2013;68:143-9
  13. Bruun RD, Budman CL,. Risperidone as a treatment for Tourette’s syndrome. J. Clin. Psychiatry. 1996;57:29-31
  14. Diantoniis MR, Henry KM, Partridge PA, Soucar E. Tics and risperidone. J. Am. Acad. Child Adolesc. Psychiatry. 1996;35:839-40
  15. Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell, PB, Peterson BS, McDougle CJ, Leckman JF. Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary